Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.

<h4>Introduction</h4>Given the current postulated plasticity between epithelial and mesenchymal states of migratory cancer cells the detection of non-epithelial CTCs is an important scientific and clinical goal.<h4>Methods</h4>We used the filtration-based ISET technology to e...

Full description

Saved in:
Bibliographic Details
Main Authors: John Castle, Karen Morris, Susan Pritchard, Cliona C Kirwan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175647&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<h4>Introduction</h4>Given the current postulated plasticity between epithelial and mesenchymal states of migratory cancer cells the detection of non-epithelial CTCs is an important scientific and clinical goal.<h4>Methods</h4>We used the filtration-based ISET technology to enrich circulating tumour cells (CTCs) in early breast cancer blood samples and identify them using a morphology-based immunocytochemistry (ICC) approach.<h4>Results</h4>We found greater numbers of putative CTCs by this approach than by the cytokeratin-based CellSearch technology, but a high number of CTC false positives were identified in healthy volunteer samples which were not reduced in successive blood draws. Preliminary work using an oestrogen receptor (ER)-based multiplex ICC method in metastatic breast cancer ISET samples indicated a low number of ER+ CTCs even at this advanced stage.<h4>Conclusions</h4>This work highlights the challenges in enumerating CTCs without conventional epithelial markers.
ISSN:1932-6203